Kuyinto engafanelekanga into yokuba isifo sofuba sisichaphazela inkqubo yokuphefumula, ngokukodwa, imiphunga. Nangona kunjalo, iibhaktheriya ezibangela ukuba isifo singene ngaphakathi kwegazi kwaye sande nakwezinye izitho. Isifo sesifo sofuba sinzima ukuxilonga kwiindawo zokuqala zophuhliso, ngoko ngokuqhelekileyo kuba yimbangela yeengxaki ezininzi ezinobungozi.
Ziziphi iifom ze-tuberculosis ezikhoyo eziphambili?
Ngokuxhomekeka kwimeko ye-pathological inflammatory processes, ezi ntlobo zilandelayo zihluke:
- inkqubo yeorrogenital;
- osteoarticular;
- lymph nodes;
- iliso;
- peritoneum;
- ukuthetha;
- isikhumba;
- izigulana
- mathumba;
- iiperiyamudi;
- isibindi;
- larynx;
- bronchi.
Iimpawu kunye nokuxilongwa kweSifo soTyhubela
Ukubonakaliswa kwezitholampilo zeentlobo ezahlukeneyo ze-pathology kumbuzo zihambelana nokutshatyalaliswa kwelungu elithile okanye inkqubo. Imiqondiso eqhelekileyo ingacingelwa:
- ukunyaniseka, ukucinga ngokukhathala;
- isifo sesifo esikuyo kwindawo yokuphuhlisa isifo sofuba;
- iimpawu zobunxila;
- umkhuhlane.
Izibonakaliso ezithile zesifo zingafana nezinye izifo (i- meningitis , i-colitis, i-conjunctivitis, i-bronchitis kunye nokunye okunjalo), ngoko ke, kunye nexesha elide, kodwa lingenakusebenza ngonyango, kuyimfuneko ukuqhagamshelana nogqirha we-TB ukujonga isifo sofuba esisisigxina.
Ukuxilongwa kukubandakanya ukuqhuba ezo zifundo:
- Ukuhlalutya ngokubanzi kwegazi , umchamo;
- ikhogram;
- iimvavanyo ze-tuberculin;
- I-X-ray, ikhompyutheni okanye i-imagination magontic resonance, i-ultrasound yelichaphazelekayo.
Unyango lwe-tuberculosis yangaphandle
Iindlela eziphambili zokulwa nale pathologi zibandakanya ukusetyenziswa kweziyobisi zokulwa ne-antibacterial kunye ne-chemotherapy ethile. Amachiza anqunywe kuphela yi-phthisiatrician esekelwe kwiziphumo zeimvavanyo ze-tuberculin, ukuqikelela ubuzwe bebhakteria kwiintlobo ezahlukeneyo ze-antibiotics.
Ukongezelela, izigulane zicetyiswa ukutya okukhethekileyo, ukuthobela ulawulo lwaloo mini, ngamanye amaxesha - uphilotherapy, ukubuyiswa kwakhona.